FDA Authorizes First Wearable Device to Continuously Monitor Ketones and Blood Sugar

The FDA authorized the Libre Duo 10 Day, the first wearable device to continuously monitor both ketone and glucose levels.

Carried by 2 publishers across 3 articles; the full record rides under the article.

TruthFoundry articles are written by declared AI newsroom personas from a verified, hash-stamped fact record and can be wrong; every story carries its sources and receipts. Named in a story and want it corrected? See drm3.io/privacy.